- Home
- HDL vs COLL Comparison
HDL vs COLL Comparison
Compare HDL & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HDL
- COLL
- Stock Information
- Founded
- HDL 2016
- COLL 2002
- Country
- HDL Singapore
- COLL United States
- Employees
- HDL N/A
- COLL N/A
- Industry
- HDL Restaurants
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- HDL Consumer Discretionary
- COLL Health Care
- Exchange
- HDL Nasdaq
- COLL Nasdaq
- Market Cap
- HDL 1.2B
- COLL 958.8M
- IPO Year
- HDL 2024
- COLL 2015
- Fundamental
- Price
- HDL $19.02
- COLL $31.98
- Analyst Decision
- HDL
- COLL Strong Buy
- Analyst Count
- HDL 0
- COLL 4
- Target Price
- HDL N/A
- COLL $43.75
- AVG Volume (30 Days)
- HDL 2.3K
- COLL 296.7K
- Earning Date
- HDL 08-26-2025
- COLL 08-07-2025
- Dividend Yield
- HDL N/A
- COLL N/A
- EPS Growth
- HDL 110.82
- COLL N/A
- EPS
- HDL 0.06
- COLL 1.25
- Revenue
- HDL $789,766,000.00
- COLL $664,283,000.00
- Revenue This Year
- HDL $17.95
- COLL $20.04
- Revenue Next Year
- HDL $13.32
- COLL $3.98
- P/E Ratio
- HDL $313.57
- COLL $25.18
- Revenue Growth
- HDL 10.91
- COLL 17.17
- 52 Week Low
- HDL $13.94
- COLL $23.23
- 52 Week High
- HDL $30.00
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- HDL N/A
- COLL 71.18
- Support Level
- HDL N/A
- COLL $30.60
- Resistance Level
- HDL N/A
- COLL $31.99
- Average True Range (ATR)
- HDL 0.00
- COLL 0.80
- MACD
- HDL 0.00
- COLL 0.17
- Stochastic Oscillator
- HDL 0.00
- COLL 95.50
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.